Table 1 General clinical characteristics of the participants.
Characteristics | Non-hypertension (n = 267) | Hypertension (n = 573) | P |
|---|---|---|---|
Age (years) | 52.06 (9.64) | 55.90 (10.24) | < 0.001 |
Sex, n (%) | 0.695 | ||
Female | 34 (12.70) | 66 (11.50) | |
Male | 233 (87.30) | 507(88.50) | |
BMI (kg /m2), n (%) | < 0.001 | ||
BMI < 18.5 | 1 (0.40) | 2 (0.30) | |
18.5 ≤ BMI < 24 | 78 (29.20) | 91 (15.90) | |
24.0 ≤ BMI < 28 | 133 (33.80) | 261 (45.50) | |
BMI ≥ 28 | 55 (20.60) | 219 (38.20) | |
WBC (× 109/L) | 5.95 (1.67) | 6.11 (1.71) | 0.183 |
Haemoglobin (g/L) | 141.72 (16.05) | 142.47 (15.18) | 0.512 |
Platelet (× 109/L) | 212.79 (52.19) | 207.71 (54.22) | 0.201 |
Neutrophil (× 109/L) | 3.54 (3.18) | 3.56 (1.28) | 0.903 |
Lymphocyte (× 109/L) | 1.95 (0.59) | 1.90 (0.69) | 0.28 |
Monocyte (× 109/L) | 0.42 (0.16) | 0.44 (0.16) | 0.055 |
NLR | 1.90 (1.63) | 2.03(1.05) | 0.004 |
ALT(U/L) | 32.37 (27.36) | 32.14 (22.34) | 0.898 |
AST(U/L) | 25.03 (10.25) | 25.87 (13.76) | 0.379 |
Creatinine(μmol/L) | 72.78 (23.53) | 75.42 (23.63) | 0.132 |
Uric acid(μmol/L) | 373.00 (81.98) | 394.89 (98.59) | 0.002 |
FPG (mmol/L) | 5.41 (1.23) | 5.84 (1.70) | < 0.001 |
Triglyceride(mmol/L) | 2.36 (2.60) | 2.90 (15.95) | 0.587 |
HDL-C(mmol/L) | 1.07 (0.32) | 1.04 (0.39) | 0.284 |
LDL-C(mmol/L) | 2.70 (0.80) | 2.60 (1.04) | 0.15 |
TyG | 8.92 (0.74) | 9.00 (0.78) | 0.166 |
TyG-BMI | 230.86 (38.41) | 245.68 (40.39) | < 0.001 |
Sleep efficiency (%) | 76.82 (16.18) | 76.98 (17.25) | 0.895 |
AHI | 29.99 (19.12) | 33.78 (19.67) | 0.009 |
Lowest SpO2(%) | 79.30 (9.29) | 77.05 (11.34) | 0.005 |
Mean SpO2(%) | 94.91 (1.97) | 94.50 (2.50) | 0.019 |
ODI | 23.56 (19.32) | 26.64 (20.16) | 0.037 |
Smoking, n (%) | 120 (44.90) | 236 (41.20) | 0.305 |
Alcohol, n (%) | 92 (34.50) | 238 (41.50) | 0.05 |
Diabetes, n (%) | 54 (20.20) | 240 (41.90) | < 0.001 |
CHD, n (%) | 37 (13.90) | 164 (28.60) | < 0.001 |
